Amniotic Dressing Shows NHS Promise - Summary - MDSpire

Amniotic Dressing Shows NHS Promise

  • July 21, 2026

  • 3 min

Share

Objective:

To evaluate the effectiveness of a sutureless amniotic membrane dressing in treating persistent corneal epithelial defects (PEDs) in patients.

Approach:
  • Study Design: Researchers at Queen Victoria Hospital NHS Foundation Trust and Maidstone and Tunbridge Wells NHS Trust reviewed real-world NHS care for patients with PEDs.
  • Treatment Method: The study compared conventional care with the use of Omnigen, a sutureless amniotic membrane dressing applied using a specialist contact lens.
Key Findings:
  • Patients treated with the sutureless approach had higher healing rates.
  • The sutureless method resulted in shorter overall treatment duration and fewer outpatient appointments.
  • Lower modelled treatment costs were associated with the sutureless amniotic membrane dressing.
Interpretation:

Limitations:
  • The study is based on real-world data and may not account for all variables affecting treatment outcomes.
  • The sample size and specific patient demographics were not detailed in the summary.
Conclusion:

Sources:

Original Source(s)

Related Content